Previous studies have found that selective NLRP3 inhibitor MCC950 was effective in ameliorating arthritic symptoms in CIA mice, indicating that NLRP3 might be involved in RA pathogenesis 33-35. This evidence concerns the gene NLRP3 and rheumatoid arthritis.